These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24492665)

  • 41. Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.
    He H; Liu L; Chen Q; Liu A; Cai S; Yang Y; Lu X; Qiu H
    Cell Transplant; 2015; 24(9):1699-715. PubMed ID: 25291359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging roles of mechanosensitive ion channels in acute lung injury/acute respiratory distress syndrome.
    Jia Q; Yang Y; Chen X; Yao S; Hu Z
    Respir Res; 2022 Dec; 23(1):366. PubMed ID: 36539808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.
    Sadeghi B; Ringdén O; Gustafsson B; Castegren M
    Front Immunol; 2022; 13():963445. PubMed ID: 36426365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?
    Xu F; Hu Y; Zhou J; Wang X
    J Cell Mol Med; 2013 Aug; 17(8):927-35. PubMed ID: 23834470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome.
    Liu C; Xiao K; Xie L
    Front Cell Dev Biol; 2022; 10():951764. PubMed ID: 36036014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Research progress of mesenchymal stem cells in the treatment of ALI].
    Zhou H; Liu M; Lyu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Nov; 29(11):1039-1042. PubMed ID: 29151424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alveolar Fluid Clearance in Pathologically Relevant Conditions:
    Huppert LA; Matthay MA
    Front Immunol; 2017; 8():371. PubMed ID: 28439268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic effects of bone marrow-derived mesenchymal stem cells on pulmonary impact injury complicated with endotoxemia in rats.
    Zhao Y; Yang C; Wang H; Li H; Du J; Gu W; Jiang J
    Int Immunopharmacol; 2013 Feb; 15(2):246-53. PubMed ID: 23273653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome.
    Lopes-Pacheco M; Robba C; Rocco PRM; Pelosi P
    Cell Biol Toxicol; 2020 Feb; 36(1):83-102. PubMed ID: 31485828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome.
    Xu AL; Rodriguez LA; Walker KP; Mohammadipoor A; Kamucheka RM; Cancio LC; Batchinsky AI; Antebi B
    Stem Cells Transl Med; 2019 Oct; 8(10):1092-1106. PubMed ID: 31219247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell therapy in acute respiratory distress syndrome.
    Horie S; Gonzalez HE; Laffey JG; Masterson CH
    J Thorac Dis; 2018 Sep; 10(9):5607-5620. PubMed ID: 30416812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors.
    Lee JW; Fang X; Krasnodembskaya A; Howard JP; Matthay MA
    Stem Cells; 2011 Jun; 29(6):913-9. PubMed ID: 21506195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesenchymal stem cell trials for pulmonary diseases.
    Antunes MA; Laffey JG; Pelosi P; Rocco PR
    J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Application of mesenchymal stem cell in the treatment of acute respiratory distress syndrome].
    Xu W; Chen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Mar; 30(3):275-279. PubMed ID: 29519290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospects and progress in cell therapy for acute respiratory distress syndrome.
    Cruz FF; Weiss DJ; Rocco PR
    Expert Opin Biol Ther; 2016 Nov; 16(11):1353-1360. PubMed ID: 27487721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stem cell derived exosomes-based therapy for acute lung injury and acute respiratory distress syndrome: A novel therapeutic strategy.
    Xu B; Chen SS; Liu MZ; Gan CX; Li JQ; Guo GH
    Life Sci; 2020 Aug; 254():117766. PubMed ID: 32418895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury.
    Brunswig-Spickenheier B; Boche J; Westenfelder C; Peimann F; Gruber AD; Jaquet K; Krause K; Zustin J; Zander AR; Lange C
    Stem Cells Dev; 2010 May; 19(5):719-29. PubMed ID: 20143956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel therapeutic strategies for acute lung injury induced by lung damaging agents: the potential role of growth factors as treatment options.
    Lindsay CD
    Hum Exp Toxicol; 2011 Jul; 30(7):701-24. PubMed ID: 20621953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat.
    Devaney J; Horie S; Masterson C; Elliman S; Barry F; O'Brien T; Curley GF; O'Toole D; Laffey JG
    Thorax; 2015 Jul; 70(7):625-35. PubMed ID: 25986435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesenchymal stem cell-based developmental endothelial locus-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice.
    Zhao YF; Xiong W; Wu XL
    Mol Med Rep; 2014 May; 9(5):1583-9. PubMed ID: 24573341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.